Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02758431 · ClinicalTrials.gov registry record · NA
Cardiovascular Outcomes of Low Testosterone
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT02758431 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 232 participants.
The verdict
NCT02758431, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
This study plans to learn more about heart and vascular aging in men. In some men as they get older, testosterone levels fall below the normal range for young men. Also, as men get older cardiovascular health worsens. This can lead to high blood pressure and heart disease. In this study we want to find out what causes cardiovascular health to worsen in older men. Also we want to find out what happens when testosterone levels are lowered for a short time. Specifically, we want to see if the reduction in cardiovascular health in older men with low testosterone levels is because of damage to mitochondria. Mitochondria are the main power supply of the cells in our body. The results from this study will help to understand why cardiovascular health declines in older men with low testosterone levels compared to younger men and older men who have higher testosterone levels. Knowing this information will help to develop therapies to prevent heart disease in men.
Interventions
- DRUG Placebo Tablet
- DRUG Placebo Gel
- DRUG Acyline
- DRUG Testosterone Gel
- DRUG Arimidex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2023-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02758431
The ClinicalTrials.gov registry entry for NCT02758431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo Tablet is the first listed.
NCT02758431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02758431 about?
NCT02758431 is a clinical study titled "Cardiovascular Outcomes of Low Testosterone". This study plans to learn more about heart and vascular aging in men. In some men as they get older, testosterone levels fall below the normal range for young men. Also, as men get older cardiovascular health worsens. This can lead to high blood pressure and heart disease. In this study we want to f...
What is the current status of trial NCT02758431?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2016-07-01. Estimated completion is 2023-01-04.
What interventions are being tested in trial NCT02758431?
The interventions under investigation include: Placebo Tablet (DRUG), Placebo Gel (DRUG), Acyline (DRUG), Testosterone Gel (DRUG), Arimidex (DRUG).
Who is sponsoring clinical trial NCT02758431?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.